MYH9 and Epstein-Barr virus infection: EBV infection of SLCs was inhibited by the NMHC‐IIA downregulation or NMHC‐IIA antibody blocking, suggesting that NMHC‐IIA is a key and fundamental host factor mediating EBV infection of SLCs.